Piperazine Based Substances of Abuse: A new Party Pills on Bulgarian Drug Market

@article{Nikolova2008PiperazineBS,
  title={Piperazine Based Substances of Abuse: A new Party Pills on Bulgarian Drug Market},
  author={Irina Nikolova and Nikolai Danchev},
  journal={Biotechnology \& Biotechnological Equipment},
  year={2008},
  volume={22},
  pages={652 - 655}
}
ABSTRACT A new 'family” of drugs, the piperazines, has emerged on the European drug market as new designer drugs for the last few years. The key members of the group that have been used for non-medical recreational purposes are BZP (Benzylpiperazine, A2, Frenzy, Nemesis), TFMPP (1-[3-(trifluoro-methyl)phenyl]piperazine), mCPP (meta-chlorophenylpiperazine, 1-(3-Chlorophenyl)-piperazine). Piperazines are psychoactive drugs and clearly not without risks. With stimulant effects comparable to… 
BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
Update on 1-benzylpiperazine (BZP) party pills
TLDR
The in vivo and in vitro studies performed in order to understand its pharmacology, toxicology and kinetics are discussed and analytical methodologies for the identification of BZP in clinical and forensic settings are addressed.
Benzylpiperazine: "A messy drug".
A Review on Benzylpiperazine and Trifluoromethylphenypiperazine: Origins, Effects, Prevalence and Legal Status
TLDR
This review would take on benzylpiperazine and trifluoromethyl piperazine as the most popular member of the piperazines, focusing the discussion on their origins, pharmacokinetics and pharmacodynamics, their effects on the human body, their evasive legal status as well as their combination as a prominent drug cocktail.
Abuse liability of novel ‘legal high’ designer stimulants: evidence from animal models
TLDR
A brief history of the recent rise in designer stimulant use is presented, a short methodological description of the aforementioned procedures are presented, and neurochemical and abuse liability studies on designer stimulants that have been examined to date are reviewed.
Drugs of Abuse and the Internet
...
...

References

The European Monitoring Centre for Drugs and Drug Addiction
TLDR
In 2013, the EMCDDA presents its annual overview of the European drug situation in a new information package designed to be 'more timely, interactive and interlinked', which replaces the former Annual report on the state of the drugs problem in Europe, traditionally published in the autumn.